Accelerating the evaluation and monitoring of new medical products
Official title: Research Triangle Center of Excellence in Regulatory Science and Innovation
Funded at Univ of North Carolina Chapel Hill · NIH-11192545 · Data updated 2026-11-12
This study is working to make sure new medical treatments and technologies are checked and monitored better, so patients can get access to safer and more effective options more quickly.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $2,033,969 |
| NIH project number | 3U01FD007857-02S2 |
| Project ID | NIH-11192545 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals who are seeking access to new and innovative medical treatments and technologies.
✕Less likely to help
Patients who are not interested in new medical technologies or who are not affected by FDA-regulated products may not receive benefit from this research.
What this research studies
This research focuses on improving the evaluation and monitoring processes for innovative medical technologies and therapeutics regulated by the FDA. By establishing the Research Triangle Center of Excellence in Regulatory Science and Innovation, the project aims to create a collaborative environment among universities and regulatory bodies to enhance methodologies for pre-market evaluations and post-marketing surveillance. Patients may benefit from more effective and timely access to new treatments and technologies as a result of improved regulatory practices.
Why it matters
Potential benefit: If successful, this research could lead to faster and safer access to innovative medical products for patients.
How similar studies have gone: Other research initiatives have shown success in improving regulatory science and methodologies, indicating that this approach has potential for meaningful advancements.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Watkins, Paul B — Univ of North Carolina Chapel Hill
- Study coordinator: Watkins, Paul B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.